The US Food and Drug Administration (USFDA) conducted an inspection of the company’s Digwal (Telangana ) based plant from February 9, 2026, to February 13, 2026
Source link
#USFDA #issues #Form #observations #Piramal #Pharmas #Telangana #unit
Trending
- Urgent Alert: Russia Prepares Massive Assault on Ukraine’s Fortress Belt
- Shocking Escalation: 352 Taliban Killed in Pakistan Border Conflict
- Stunning Escalation: Iran Hit by Massive US-Israeli Airstrikes
- Stunning Escalation: Pakistan-Afghanistan War Reignites Critical Border Clash
- India’s Historic Chip Push: Micron’s Gujarat Plant Now Live
- India’s Major Chip Leap: Micron Plant Powers “Made-in-India” Memory
- England’s Stunning T20 Dominance: Pakistan’s Semi-Final Hopes Fade
- Stunning Crypto Regulatory Shift: US SEC Embraces Capital-Friendly Approach
USFDA issues Form 483 with 4 observations to Piramal Pharma’s Telangana unit
